ArticleNature genetics2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Comparative spatial whole transcriptome analysis of matched frozen and formalin-fixed paraffin-embedded colorectal cancer tissues.Biochemistry and biophysics reports · 2026Article
- Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.Nature genetics · 2026Article
- Smad4 and TGFβ1 dependent gene expression signatures in conditional intestinal adenoma, organoids and colorectal cancer.Scientific reports · 2025Article
- Prognostic and Predictive Value of SARIFA-status Within Molecular Subgroups of Colorectal Cancer: Insights From the Netherlands Cohort Study.The American journal of surgical pathology · 2025Article
- Artificial Intelligence in Colorectal Cancer: From Patient Screening over Tailoring Treatment Decisions to Identification of Novel Biomarkers.Digestion · 2024Review
Corrections and comments
- Erratum for
Authors and funding
44 authors.
Sudhir B MallaThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0001-5862-3815
Ryan M Byrne *The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0001-6505-6345
Maxime W Lafarge *Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Shania M CorryThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Natalie C FisherThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0003-1769-7468
Petros K TsantoulisFaculty of Medicine, Université de Genève, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-3613-6682
Megan L MillsCancer Research UK Scotland Institute, Glasgow, UK.
Rachel A RidgwayCancer Research UK Scotland Institute, Glasgow, UK.ORCID http://orcid.org/0000-0003-0198-8244
Tamsin R M LannaganCancer Research UK Scotland Institute, Glasgow, UK.
Arafath K NajumudeenCancer Research UK Scotland Institute, Glasgow, UK.
Kathryn L GilroyCancer Research UK Scotland Institute, Glasgow, UK.ORCID http://orcid.org/0000-0003-4607-194X
Raheleh AmirkhahThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0003-3494-271X
Sarah L MaguireThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0001-6654-3620
Eoghan J MulhollandCentre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1200-9825
Hayley L Belnoue-DavisCentre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2914-4932
Elena GrassiCandiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.ORCID http://orcid.org/0000-0003-1066-927X
Marco VivianiCandiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.ORCID http://orcid.org/0000-0003-4698-8870
Emily RoganThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Keara L RedmondThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Svetlana SakhnevychThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Aoife J McCooeyThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Courtney BullThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Emily HoeyThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Nicoleta SineviciThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Holly HallCancer Research UK Scotland Institute, Glasgow, UK.ORCID http://orcid.org/0000-0003-2779-2565
Baharak AhmaderaghiSchool of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0003-4166-6290
Enric DomingoDepartment of Oncology, University of Oxford, Oxford, Oxfordshire, UK.ORCID http://orcid.org/0000-0003-4390-8767
Andrew BlakeDepartment of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
Susan D RichmanLeeds Institute of Medical Research, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-3993-5041
Claudio IsellaCandiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
Crispin MillerCancer Research UK Scotland Institute, Glasgow, UK.
Andrea BertottiCandiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.
Livio TrusolinoCandiolo Cancer Institute, FPO IRCCS, Candiolo, Torino, Italy.ORCID http://orcid.org/0000-0002-6379-3365
Maurice B LoughreyThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Emma M KerrThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0002-1952-4213
Sabine TejparDepartment of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-3281-8643
S:CORT consortium
Timothy S MaughanDepartment of Oncology, University of Oxford, Oxford, Oxfordshire, UK.
Mark LawlerThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Andrew D CampbellCancer Research UK Scotland Institute, Glasgow, UK.ORCID http://orcid.org/0000-0003-3930-1276
Simon J LeedhamCentre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1476-6982
Viktor H KoelzerDepartment of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9206-4885
Owen J SansomCancer Research UK Scotland Institute, Glasgow, UK.ORCID http://orcid.org/0000-0001-9540-3010
Philip D DunneThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. p.dunne@qub.ac.uk.ORCID http://orcid.org/0000-0001-9160-283X
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.